Analysis and Commentary 6/29/17 Analysis and Commentary 6/29/17 Happier ... But Not Out of the Woods by Any Means Read More Advocacy at a Glance 6/29/17 Advocacy at a Glance 6/29/17 Advocacy at a Glance Read More 6/29/17 6/29/17 Alliance Applauds House Ag/FDA Appropriations Subcommittee Read More Analysis and Commentary 6/23/17 Analysis and Commentary 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More Advocacy at a Glance 6/23/17 Advocacy at a Glance 6/23/17 Advocacy at a Glance Read More Analysis and Commentary 6/16/17 Analysis and Commentary 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More Advocacy at a Glance 6/16/17 Advocacy at a Glance 6/16/17 Advocacy at a Glance Read More Analysis and Commentary 6/9/17 Analysis and Commentary 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More Advocacy at a Glance 6/9/17 Advocacy at a Glance 6/9/17 Advocacy at a Glance Read More Analysis and Commentary 5/31/17 Analysis and Commentary 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More Advocacy at a Glance 5/31/17 Advocacy at a Glance 5/31/17 Advocacy at a Glance Read More Analysis and Commentary 5/26/17 Analysis and Commentary 5/26/17 The Good News; the Bad News; and What's Next? Read More Advocacy at a Glance 5/26/17 Advocacy at a Glance 5/26/17 Advocacy at a Glance Read More 5/23/17 5/23/17 President Trump's FY 18 Budget Request Threatens FDA's Mission Read More Advocacy at a Glance 5/19/17 Advocacy at a Glance 5/19/17 How a 6% Budget Increase Can Actually Be a 45% Decrease Read More Advocacy at a Glance 5/19/17 Advocacy at a Glance 5/19/17 Advocacy at a Glance Read More Analysis and Commentary 5/12/17 Analysis and Commentary 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More Advocacy at a Glance 5/12/17 Advocacy at a Glance 5/12/17 Advocacy at a Glance Read More Analysis and Commentary 5/5/17 Analysis and Commentary 5/5/17 Time for Some Heartfelt "Thank you"s Read More Advocacy at a Glance 5/5/17 Advocacy at a Glance 5/5/17 Advocacy at a Glance Read More Newer Posts Older Posts
Analysis and Commentary 6/29/17 Analysis and Commentary 6/29/17 Happier ... But Not Out of the Woods by Any Means Read More
Analysis and Commentary 6/23/17 Analysis and Commentary 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More
Analysis and Commentary 6/16/17 Analysis and Commentary 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More
Analysis and Commentary 6/9/17 Analysis and Commentary 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More
Analysis and Commentary 5/31/17 Analysis and Commentary 5/31/17 How the Federal Budget Applies to the FDA -- A Refresher for FY 18 Read More
Analysis and Commentary 5/26/17 Analysis and Commentary 5/26/17 The Good News; the Bad News; and What's Next? Read More
Advocacy at a Glance 5/19/17 Advocacy at a Glance 5/19/17 How a 6% Budget Increase Can Actually Be a 45% Decrease Read More
Analysis and Commentary 5/12/17 Analysis and Commentary 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
Analysis and Commentary 5/5/17 Analysis and Commentary 5/5/17 Time for Some Heartfelt "Thank you"s Read More
